Diakine-DK2 10 (CD19)

N/A

Report date: 2023/03/07 16:09:38

Base Information

Drug NameDiakine-DK2 10 (CD19)
Drug Alias NameDiakine™- DK2 10 (CD19)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-2 receptor agonistsInterleukin 10 receptor stimulantsAnti-CD19
TargetsInterleukin-2 receptorInterleukin 10 receptorB-lymphocyte antigen CD19
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDeka Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesDeka Biosciences Inc
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A